A short ETV Bharat piece on who GLP-1 weight loss shots may or may not be right for, framed as a general question about obesity treatment.
Recap by typeshit. Post by ETV Bharat on X.
Women on CagriSema hit 20% weight loss far more often than on semaglutide alone, 68.7% vs 38.0%, though Novo calls the comparisons exploratory.
The Sugarfit co-founder and the doctor argue that managing weight on GLP-1 medications takes more than the drug by itself.
European Business Magazine says oral Wegovy has 1.5 million patients and about $843m in first-half sales, while semaglutide generics spread in India and Canada.
Rooney says the Ozempic rumors are wrong, that he is working to look better and be healthier, and that he has stopped drinking alcohol for a while.
Harvard's Pieter Cohen and Johns Hopkins' Caleb Alexander advise against unapproved injectable peptides as HHS reportedly plans to let pharmacies compound some.
The obesity doctor responds to upset replies on an earlier post, holding that adiposity and cardiorespiratory fitness are correlated yet separate measures.
Loading…